endometriosis – media

Elagolix soon to be Available for Endometriosis Treatment

A new therapeutic pill named elagolix will now become available for endometriosis-related pain, after getting approved by the US Food and Drug Administration. This newly-approved drug can be taken for longer durations but also has several side-effects like headaches, hot flushes and nausea.
- Source: NewScientist
- 833
- July 31, 2018
endometriosis New Approvals
Endometriosis in Adulthood linked with Abuse in Childhood

A 20 percent to 50 percent higher risk of developing endometriosis in women with a past of sexual or emotional abuse was observed by a European study published in the journal, Human Reproduction. Similarly, a large U.S. study in the same journal yielded matching results with sexual or physical abuse in the past.
- Source: Reuters
- 498
- July 27, 2018
endometriosis Researches
FDA Prolongs Review Date for AbbVie Endometriosis Candidate

The FDA extends the review period of NDA for AbbVie (ABBV) and partner Neurocrine Biosciences' endometriosis candidate, elagolix, by three months to third-quarter 2018.
- Source: finance.yahoo
- 539
- April 12, 2018
elagolix endometriosis New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.